Price-cost margin in the pharmaceutical industry: Empirical evidence from Finland

Author： Linnosmaa Ismo   Hermans Raine   Hallinen Taru  

Publisher： Springer Publishing Company

ISSN： 1618-7598

Source： The European Journal of Health Economics, Vol.5, Iss.2, 2004-05, pp. : 122-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effects of unethical conduct of pharmaceutical companies on consumer behavior: Empirical evidence from Germany

By Lindenmeier Jörg   Tscheulin Dieter K.   Drevs Florian  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 6, Iss. 2, 2012-06 ,pp. : 108-123

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

University-industry knowledge interaction: case studies from Finland and China

By Hong Jianzhong   Olander Heidi  

International Journal of Healthcare Technology and Management, Vol. 11, Iss. 5, 2010-10 ,pp. : 356-372

Inderscience Publishers

Access to resources Recommend Favorite

THE PHARMACEUTICAL INDUSTRY; AN EASY TARGET

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 18, Iss. 5, 1970-05 ,pp. : 387-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

The herbal pharmaceutical industry in India

By Moulin Anne-Marie  

Médecine/sciences, Vol. 32, Iss. 10, 2016-10 ,pp. : 895-897

Edp Sciences

Access to resources Recommend Favorite

The impact of generic substitution on price competition in Finland

By Aalto-Setälä Ville  

The European Journal of Health Economics, Vol. 9, Iss. 2, 2008-05 ,pp. : 185-191

Springer Publishing Company

Access to resources Recommend Favorite